Second Circuit Issues Long-Anticipated Decision In Caronia – Pharmaceutical Misbranding Conviction Reversed On First Amendment Grounds
Drug manufacturers may not be prosecuted for promoting off-label uses of their products, the U.S. Court of Appeals for the Second Circuit ruled Monday. The court concluded that federal drug...
read more